Switzerland's Roche and Novartis and other drugmakers are touting new treatments for a blindness-causing disease that hits millions of older people, as patent expiries are set to open up one of medicine's most lucrative markets.
from Reuters: Health https://ift.tt/2zcH2xX
via
IFTTT
0 comments: